PMG Family Office LLC Makes New Investment in BlackRock Science and Technology Term Trust $BSTZ

PMG Family Office LLC purchased a new stake in BlackRock Science and Technology Term Trust (NASDAQ:BSTZ) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 59,060 shares of the company’s stock, valued at approximately $1,309,000. BlackRock Science and Technology Term Trust accounts for approximately 1.5% of PMG Family Office LLC’s holdings, making the stock its 23rd largest position.

A number of other hedge funds and other institutional investors have also made changes to their positions in BSTZ. US Bancorp DE raised its position in shares of BlackRock Science and Technology Term Trust by 165.3% during the 3rd quarter. US Bancorp DE now owns 1,804 shares of the company’s stock valued at $40,000 after buying an additional 1,124 shares during the period. Geneos Wealth Management Inc. purchased a new position in BlackRock Science and Technology Term Trust in the first quarter worth approximately $40,000. Allworth Financial LP grew its position in BlackRock Science and Technology Term Trust by 11,764.7% in the second quarter. Allworth Financial LP now owns 2,017 shares of the company’s stock worth $42,000 after acquiring an additional 2,000 shares during the period. AdvisorNet Financial Inc increased its stake in BlackRock Science and Technology Term Trust by 47.6% during the third quarter. AdvisorNet Financial Inc now owns 3,731 shares of the company’s stock worth $83,000 after acquiring an additional 1,204 shares during the last quarter. Finally, Newbridge Financial Services Group Inc. acquired a new stake in BlackRock Science and Technology Term Trust during the second quarter worth $123,000.

Insider Transactions at BlackRock Science and Technology Term Trust

In related news, Portfolio Manager Tony Kim bought 41,825 shares of the firm’s stock in a transaction on Thursday, February 5th. The shares were bought at an average price of $22.00 per share, with a total value of $920,150.00. Following the completion of the transaction, the portfolio manager directly owned 251,554 shares of the company’s stock, valued at $5,534,188. This represents a 19.94% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

BlackRock Science and Technology Term Trust Stock Performance

NASDAQ:BSTZ opened at $21.79 on Thursday. BlackRock Science and Technology Term Trust has a 52 week low of $15.22 and a 52 week high of $23.47. The stock’s fifty day moving average is $22.51 and its two-hundred day moving average is $22.38.

BlackRock Science and Technology Term Trust Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be issued a $0.1625 dividend. This represents a c) annualized dividend and a yield of 9.0%. The ex-dividend date is Monday, June 15th.

BlackRock Science and Technology Term Trust Profile

BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.

The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.